Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer
Minhong Shen(Fudan University Shanghai Cancer Center), Yibin Kang(Rutgers, The State University of New Jersey), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), Yong Wei(The Ohio State University), Zhi‐Ming Shao(Fudan University Shanghai Cancer Center), Sheng Zhao(Fudan University Shanghai Cancer Center), Liling Wan(University of Pennsylvania), Heath A. Smith(AbbVie (United States)), Xiang Hang(Christian-Albrechts-Universität zu Kiel), Song‐Yang Wu(Shanghai Medical College of Fudan University), Yong Tang(Chengdu University of Traditional Chinese Medicine), Nicole Wang(Princeton University), Michelle Rowicki(Princeton University)
Cited by 84
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k